StockWatch
·
Ophthalmic Goods
Quarterly ResultApr 29, 2026, 04:53 PM

BLCO Q1 Revenue +9.4% to $1.24B; Net Loss $(71)M; Operating Income $33M

AI Summary

Bausch & Lomb Corp reported a strong first quarter for 2026, with revenues increasing by 9.4% to $1.24 billion. The company significantly improved its operating performance, moving from an operating loss of $(83) million in Q1 2025 to an operating income of $33 million in Q1 2026. Net loss attributable to Bausch + Lomb Corporation was substantially reduced to $(71) million, a 66.5% improvement from the prior year's $(212) million loss. The company also generated $32 million in cash from operating activities, compared to using $(25) million in the same period last year, while BHC continues to evaluate the separation of Bausch + Lomb.

Key Highlights

  • Q1 2026 Revenue increased 9.4% to $1.24 billion from $1.14 billion YoY.
  • Q1 2026 Operating Income was $33 million, compared to a $(83) million loss YoY.
  • Q1 2026 Net Loss attributable to BLCO reduced 66.5% to $(71) million.
  • Basic and diluted loss per share improved to $(0.20) from $(0.60) YoY.
  • Net cash provided by operating activities was $32 million, up from $(25) million used YoY.
  • BHC holds approximately 87% of BLCO common shares as of April 22, 2026.
  • BHC continues to evaluate the separation of Bausch + Lomb, including potential sale or distribution.